Market Place
Sourcing Support
Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
03 May 2024 //
PR NEWSWIRE
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year
02 Apr 2024 //
BIOSPACE
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
01 Apr 2024 //
GLOBENEWSWIRE
Eiger and Partner, AnGes, Receive Approval for Zokinvy) for Hutchinson
18 Jan 2024 //
PR NEWSWIRE
EigerBio`s Zokinvy (lonafarnib) Receives Approval in Europe
24 Mar 2023 //
EMA
Eiger to Host Conference to Discuss Phase 3 D-LIVR Study Results of Lonafarnib
07 Dec 2022 //
PRNEWSWIRE
AnGes and Eiger collaborate to distribute Zokinvy in Japan
11 May 2022 //
PHARMACEUTICAL-TECHNOLOGY
Eiger concludes subject enrolment in Phase III HDV drug trial
01 Nov 2021 //
CLINICALTRIALSARENA
Eiger BioPharmaceuticals Receives Rare Impact Award for Innovation from the NORD
29 Jun 2021 //
PR NEWSWIRE
The top 20 most expensive pharmacy drugs in the U.S. in 2021
09 Mar 2021 //
FIERCEPHARMA
FDA approves first treatment for rare paediatric genetic diseases
24 Nov 2020 //
EUROPEANPHARMACEUTICALREVIEW
FDA approves first drug, Eiger`s Zokinvy, for rare rapid-aging disease
24 Nov 2020 //
FIERCEPHARMA
FDA approves first drug, Eiger`s Zokinvy, for rare rapid-aging disease
23 Nov 2020 //
FIERCE PHARMA
Eiger BioPharmaceuticals Sells Priority Review Voucher for $95 Million
23 Nov 2020 //
PRNEWSWIRE
Eiger Announces Positive Peginterferon Lambda - Lonafarnib End of Study Results
17 Nov 2020 //
PRNEWSWIRE
Eiger Announces Abstracts Highlighting Peginterferon Lambda and Lonafarnib
02 Nov 2020 //
PRNEWSWIRE
Eiger Announces FDA Acceptance of NDA for Filing with Priority of Zokinvy™
19 May 2020 //
PR NEWSWIRE
Eiger`s Announces EMA Validation of Lonafarnib MAA for Treatment
27 Apr 2020 //
PR NEWSWIRE
Eiger Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria
27 Apr 2020 //
PR NEWSWIRE
Eiger Completes Submission of New Drug Application to FDA for Lonafarnib
23 Mar 2020 //
PR NEWSWIRE
Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Result
12 Nov 2019 //
PR NEWSWIRE
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide
19 Jun 2019 //
PR NEWSWIRE
Eiger BioPharma gets patent protection for HDV drug in Europe and Japan
08 Feb 2019 //
BIOSPECTRUM
Eiger To Seek FDA Approval Of Progeria Therapy
04 Sep 2018 //
BIOCENTURY
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.